未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trialSHR7280,一种口服促性腺激素释放激素拮抗剂,用于预防控制性卵巢过度刺激中的黄体生成素过早激增:一项剂量探索性II期试验
Chi, Hongbin; Song, Ying; Jin, Lei; Song, Xueru; Wang, Xiaohong; Ma, Qianhong; Cao, Yunxia; Liang, Xiaoyan; Tan, Jichun; Guan, Yichun; Diao, Feiyang; Li, Yanping; Li, Zeli; Sun, Yuqi; Shu, Chang; Chen, Hong; Shen, Kai
分享
收藏
分享
收藏Ripretinib used for preoperative treatment of metastatic gastrointestinal stromal tumor after failure of imatinib therapy瑞普替尼用于伊马替尼治疗失败后的转移性胃肠道间质瘤的术前治疗
Yang, L.; Lin, T.; Gao, X.; Zhou, Y.; Sun, X.; Zhang, Z.; Cao, H.; Qian, H.; Shen, K.; Wang, M.
分享
收藏Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
Cheng, Yuanzhi; Hu, Xiaotong; Pei, Zejun; Zhang, Zhe; Lin, Hongda; Feng, Sheng; Gao, Zhenyan; Ma, Yanlin; Cao, Zhihai; Zhang, Qian; Zheng, Liang; Zhang, Wei; Shen, Kai; Hu, Wei
分享
收藏
分享
收藏Prognostic value of [18F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study
Li, Ang; Shen, Kai; Ji, Yiyi; Zhang, Weiwei; Liu, Bo; Su, Ruopeng; Zhou, Xiang; Dong, Liang; Zhu, Yinjie; Dong, Baijun; Pan, Jiahua; Wang, Qi; Xue, Wei
分享
收藏The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects
Ma, Tingting; Weng, Zuyi; Cao, Bei; Dong, Yanli; Deng, Chanjuan; Huang, Lei; Yang, Yuanxun; Wang, Yuqi; Shen, Chenxi; Wang, Lei; Shen, Kai; Li, Juan
分享
收藏Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
Yang, Ling; Fang, Yuan; Luo, Yuan; Fu, Meng; Shen, Kai; Luo, Zhu
分享
收藏
分享
收藏
分享
收藏Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities
Zhou, Ya-ting; Chu, Jia-hui; Zhao, Shu-han; Li, Ge-li; Fu, Zi-yi; Zhang, Su-jie; Gao, Xue-hu; Ma, Wen; Shen, Kai; Gao, Yuan; Li, Wei; Yin, Yong-mei; Zhao, Chen
分享
收藏
分享
收藏
分享
收藏The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer
Ji, Yiyi; Zhang, Weiwei; Shen, Kai; Su, Ruopeng; Liu, Xinyu; Ma, Zehua; Liu, Bo; Hu, Cong; Xue, Yizheng; Xin, Zhixiang; Yang, Yi; Li, Ang; Jiang, Zhou; Jing, Na; Zhu, Helen He; Dong, Liang; Zhu, Yinjie; Dong, Baijun; Pan, Jiahua; Wang, Qi; Xue, Wei
分享
收藏
分享
收藏